Aktuellt
SENASTE
Vitrolife continues to improve its organic growth, and the company has delivered two quarters with close-to-market growth. The reported Q3 sales are below expectations due to a higher FX headwind by 5%. Vitrolife is now on track to reinstalling a growth rate closer to its long-term target of >10%.
LÄS MER
